Barcode-enabled sequencing of plasmablast antibody repertoires in rheumatoid arthritis

Arthritis and Rheumatology

Volumn 66, Issue 10, 2014, Pages 2706-2715

  Tan, Yann Chong ^a,b,c   Kongpachith, Sarah ^a,b   Blum, Lisa K ^a,b   Ju, Chia Hsin ^a,b   Lahey, Lauren J ^a,b   Lu, Daniel R ^a,b   Cai, Xiaoyong ^a,b   Wagner, Catriona A ^a,b   Lindstrom, Tamsin M ^a   Sokolove, Jeremy ^a,b   Robinson, William H ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Atreca Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; CELL ANTIBODY; COMPLEMENTARY DNA; EPITOPE; FIBRINOGEN; HISTONE H2B; MONOCLONAL ANTIBODY; PLASMABLAST ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA BARCODING; HEAVY CHAIN; HIGH THROUGHPUT SEQUENCING; HUMAN; LIGHT CHAIN; MICROARRAY ANALYSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENETIC TREE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; BLOOD; GENETICS; IMMUNOLOGY; PLASMA CELL;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; B-LYMPHOCYTES; DNA BARCODING, TAXONOMIC; EPITOPES; HUMANS; PLASMA CELLS;

EID: 84905982405     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38754     Document Type: Article

References (39)

1. McInnes IB, Schett G,. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
2. Firestein GS,. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-61.
3. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ,. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
4. Van Venrooij WJ, van Beers JJ, Pruijn GJ,. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011; 7: 391-8.
5. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
6. Klein F, Halper-Stromberg A, Horwitz JA, Gruell H, Scheid JF, Bournazos S, et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 2012; 492: 118-22.
7. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011; 333: 850-6.
8. Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009; 458: 636-40.
9. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TY, et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 2011; 333: 1633-7.
10. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004; 10: 871-5.
11. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453: 667-71.
12. Fischer N,. Sequencing antibody repertoires: the next generation. MAbs 2011; 3: 17-20.
13. DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol 2013; 31: 166-9.
14. Cheung WC, Beausoleil SA, Zhang X, Sato S, Schieferl SM, Wieler JS, et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat Biotechnol 2012; 30: 447-52.
15. Tan YC, Blum LK, Kongpachith S, Ju CH, Cai X, Lindstrom TM, et al. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin Immunol 2014; 151: 55-65.
16. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T, et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; 6: 741-50.
17. Fink K,. Origin and function of circulating plasmablasts during acute viral infections. Front Immunol 2012; 3: 78.
18. Shlomchik MJ, Weisel F,. Germinal center selection and the development of memory B and plasma cells. Immunol Rev 2012; 247: 52-63.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
20. Schmidt WM, Mueller MW,. CapSelect: a highly sensitive method for 5′ CAP-dependent enrichment of full-length cDNA in PCR-mediated analysis of mRNAs. Nucleic Acids Res 1999; 27: e31.
21. Alamyar E, Giudicelli V, Li S, Duroux P, Lefranc MP,. IMGT/HighV-QUEST: the IMGT web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing. Immunome Res 2012;8:1:2. URL: http://www.imgt.org/PDF/ImmunomeRes/8-1-15-2012.pdf.
22. Edgar RC,. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32: 1792-7.
23. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O,. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010; 59: 307-21.
24. Huerta-Cepas J, Dopazo J, Gabaldon T,. ETE: a python Environment for Tree Exploration. BMC Bioinformatics 2010; 11: 24.
25. Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF, et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005; 52: 2645-55.
26. Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012; 7: e35296.
27. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002; 8: 295-301.
28. Kerkman PF, Rombouts Y, van der Voort EI, Trouw LA, Huizinga TW, Toes RE, et al. Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis. Ann Rheum Dis 2013; 72: 1259-63.
29. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41: 1319-24.
30. Lundberg K, Bengtsson C, Kharlamova N, Reed E, Jiang X, Kallberg H, et al. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 2013; 72: 652-8.
31. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J Immunol 2001; 166: 4177-84.
32. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R94.
33. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961-73.
34. Owczarczyk K, Lal P, Abbas AR, Wolslegel K, Holweg CT, Dummer W, et al. A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Sci Transl Med 2011; 3: 101ra92.
35. Sokolove J, Zhao X, Chandra PE, Robinson WH,. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum 2011; 63: 53-62.
36. Rohrbach AS, Slade DJ, Thompson PR, Mowen KA,. Activation of PAD4 in NET formation. Front Immunol 2012; 3: 360.
37. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013; 5: 178ra40.
38. Knight JS, Carmona-Rivera C, Kaplan MJ,. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Front Immunol 2012; 3: 380.
39. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med 2009; 1: 12ra23.